Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment.
about
Histone deacetylases as targets for treatment of multiple diseasesEnhancement of inflammatory protein expression and nuclear factor Κb (NF-Κb) activity by trichostatin A (TSA) in OP9 preadipocytesc-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors.Epigenetic modifiers reduce inflammation and modulate macrophage phenotype during endotoxemia-induced acute lung injury.Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).Inhibition of histone deacetylase 1 or 2 reduces induced cytokine expression in microglia through a protein synthesis independent mechanism.A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities.Substance P induces CCN1 expression via histone deacetylase activity in human colonic epithelial cells.Histone deacetylase 5 regulates the inflammatory response of macrophages.Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury.Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice.Integrative functional genomic delineation of the cascades of transcriptional changes involved in hepatocellular carcinoma progression.
P2860
Q27000389-2DE0089E-2B91-47B8-86DD-EAD0E66C1B5FQ34651949-6813484E-5AE5-4C5C-A59B-8807C680FAFEQ34667550-5AB0143C-48B4-45A1-BF18-1097CBEBD622Q35969116-9162ED58-E274-4497-B797-3723AA09408AQ36799721-DB70B0FE-E6CC-49DE-AF31-63A08BCAFFD2Q38630674-5E1D0576-5787-41E9-BB2C-97EC94D33ACBQ38818334-097EACAD-632E-4B2E-ACA0-F22372D60174Q38865042-38C2644D-1F81-4138-961C-410E313427A4Q41172414-78FE878A-BEFB-4CB8-B2E7-9A315D52DED3Q42758806-10511BFF-0F0A-4A01-9D06-CD54F76F64F8Q44674787-00F7A528-63E4-488C-8A39-09C07251A8CDQ50967286-4ECBE62E-7D13-42FA-B1FF-23A46A9A4533Q53089247-D3470B27-7D31-4EBE-91E9-BC1059842EC8
P2860
Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Histone deacetylase inhibitors ...... RNA polymerase II recruitment.
@en
Histone deacetylase inhibitors ...... RNA polymerase II recruitment.
@nl
type
label
Histone deacetylase inhibitors ...... RNA polymerase II recruitment.
@en
Histone deacetylase inhibitors ...... RNA polymerase II recruitment.
@nl
prefLabel
Histone deacetylase inhibitors ...... RNA polymerase II recruitment.
@en
Histone deacetylase inhibitors ...... RNA polymerase II recruitment.
@nl
P2093
P2860
P1433
P1476
Histone deacetylase inhibitors ...... RNA polymerase II recruitment.
@en
P2093
Akihiro Ito
Akiko Saito
Kenji Ogawa
Norikazu Nishino
Ryohei Furumai
Satoko Maeda
Sueharu Horinouchi
P2860
P304
P356
10.1111/J.1349-7006.2011.01904.X
P577
2011-03-04T00:00:00Z